Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

By sjmartinez • October 19, 2023

Jagannathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Main MJ, Monk PD, Javan AC, Li JZ, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W; ACTIV-2/A5401 Study Team. Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial. EClinicalMedicine. 2023 Oct 6;65:102250. doi: 10.1016/j.eclinm.2023.102250. PMID: 37855026; PMCID: PMC10579289.

Tags: ACTIV-2, covid-19, Infectious Diseases, Inhaled interferon, Publications, Randomized clinical trial, SARS-CoV-2

Prompt Initiation of Maternal Antiretroviral Therapy After HIV Seroconversion in Pregnancy Effectively Prevents Vertical Transmission and Other Adverse Infant Outcomes

Sundar KG, Yang LZ, Cambou MC, Varella IRS, Melo MG, Segura ER, Ziegler ÂP, Santos BR, Nielsen-Saines K. Prompt Initiation of Maternal Antiretroviral Therapy After[...]

Factors Associated With PrEP Utilization and Access in the United States

David HM, Martin T, Wells A, Little SJ, Mehta S. Factors Associated With PrEP Utilization and Access in the United States. AIDS Educ Prev. 2024[...]

The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment

Cosgrove SE, Miller LG. The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment? JAMA Netw Open. 2024 Dec 2;7(12):e2451300. doi: 10.1001/jamanetworkopen.2024.51300. PMID: 39705037.